This is a $2,547.92 firm fixed-price delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The order is for the delivery of DEXAMETHASONE 0.5 MG/5 ML ELX 237ML, a medication, with a performance period ending on May 29, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, designated as SPE2DX, which provides a comprehensive global...
This is a $1,046.44 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,567,883,375 units of dexamethasone 4 mg tablets. The contract has an ultimate completion date of April 14, 2025 and was awarded on April 11, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $6,969.35 firm fixed-price contract is for the supply of 4558476695 DEXAMETHASONE 20 MG/5 ML VIAL 5ML, with a completion date of September 16, 2022. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical...
This federal contract award is a delivery order to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of DEXAMETHASONE 4 MG TABLET 100S. The contract has a ceiling value of $1,011.00 and is a firm fixed price award from the Defense Logistics Agency, a defense agency. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the Defense...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of DEXAMETHASONE 20 MG/5 ML VIAL 5ML, a pharmaceutical product, with a ceiling value of $1,208.84 and an ultimate completion date of January 31, 2025. The contract is not designated with any set-aside requirements, indicating open competition. Amerisourcebergen Drug...
This is a Delivery Order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, under an Indefinite Delivery Contract (IDC) valued at $999,999,999. The order is for DEXAMETHASONE 6 MG TABLET UD 100S, with a ceiling value of $2,709. The contract has a firm fixed price and is set to be completed by January 10, 2024. There is no set-aside designation for this award. AmerisourceBergen, as the prime contractor, will be responsible for...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of DEXAMETHASONE 0.5 MG/5 ML ELX 237ML, a pharmaceutical product, with a ceiling value of $1,939.02 and a period of performance through May 21, 2025. The contract is a firm fixed price, non-set-aside award, indicating open competition. Amerisourcebergen Drug Corp is a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,821.09 firm fixed-price delivery order is for the supply of 4564520594 - DEXAMETHASONE 10 MG/ML VIALML, with a period of performance ending on May 8, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,236.93, is for the delivery of 4568346564 Dexamethasone 20 mg/5 mL vials. The contract has an ultimate completion date of May 27, 2025. Amerisourcebergen Drug Corp is the prime contractor and this award is not associated with a set-aside program. The company holds a...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $1,715.78, is for the delivery of dexamethasone 20 mg/5 ml vials with a final completion date of April 16, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract...